Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,747,242
-
Share change
-
-379,523
-
Total reported value
-
$14,607,000
-
Put/Call ratio
-
124%
-
Price per share
-
$1.67
-
Number of holders
-
35
-
Value change
-
-$653,257
-
Number of buys
-
14
-
Number of sells
-
12
Institutional Holders of KEMPHARM INC - COM (KMPH) as of Q1 2019
As of 31 Mar 2019,
KEMPHARM INC - COM (KMPH) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,747,242 shares.
The largest 10 holders included
DSC Advisors, L.P., Alyeska Investment Group, L.P., VANGUARD GROUP INC, Arete Wealth Advisors, LLC, Creative Planning, COWEN INC., GEODE CAPITAL MANAGEMENT, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, BRIDGEWAY CAPITAL MANAGEMENT INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.